Paula J. Ehrlich
Directeur Général chez E. O. Wilson Biodiversity Foundation
Profil
Paula J.
Ehrlich is currently the President, Chief Executive Officer & Director at E.
O.
Wilson Biodiversity Foundation since 2012.
Prior to this, she worked as a Senior Director-Scientific Affairs at Locus Pharmaceuticals, Inc. and as a Principal at Merck Research Laboratories Massachusetts LLC.
She completed her undergraduate degree at Duke University and her doctorate at University College London.
Postes actifs de Paula J. Ehrlich
| Sociétés | Poste | Début |
|---|---|---|
E. O. Wilson Biodiversity Foundation
 E. O. Wilson Biodiversity Foundation Miscellaneous Commercial ServicesCommercial Services E. O. Wilson Biodiversity Foundation is a non-profit organization. It focuses on education, technology, and business strategies to further the preservation of biodiversity. The company was founded by Jay M. Short, Neil Patterson, and Charles J. Smith in 2005 and is headquartered in Durham, NC. | Directeur Général | 10/07/2012 |
Anciens postes connus de Paula J. Ehrlich
| Sociétés | Poste | Fin |
|---|---|---|
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Corporate Officer/Principal | 01/01/2008 |
Locus Pharmaceuticals, Inc.
 Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Directeur Technique/Scientifique/R&D | 11/05/2010 |
Formation de Paula J. Ehrlich
| Duke University | Undergraduate Degree |
| University College London | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Locus Pharmaceuticals, Inc.
Locus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Locus Pharmaceuticals is a pharmaceutical company focused on developing novel, small molecule therapeutics to address major unmet medical needs. Locus utilizes powerful and proprietary computational technologies running on Linux-based supercomputer clusters to simultaneously identify relevant binding sites on protein disease targets and rapidly generate novel, small molecules that bind specifically to those protein sites. In contrast to other computational approaches, the Locus technology requires only a high-resolution, 3-dimensional structure of the target protein to implement its drug discovery process. Locus Pharmaceuticals is synthesizing and testing novel drug candidates for the treatment of debilitating and life-threatening human diseases, including HIV/AIDS, cancer, arthritis and inflammation. | Health Technology |
Merck Research Laboratories Massachusetts LLC
Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Health Technology |
E. O. Wilson Biodiversity Foundation
E. O. Wilson Biodiversity Foundation Miscellaneous Commercial ServicesCommercial Services E. O. Wilson Biodiversity Foundation is a non-profit organization. It focuses on education, technology, and business strategies to further the preservation of biodiversity. The company was founded by Jay M. Short, Neil Patterson, and Charles J. Smith in 2005 and is headquartered in Durham, NC. | Commercial Services |
